Acne Medication Market by Therapeutic Class (Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, and Others), Formulation (Topical Medications and Oral Medications), Type (Prescription Medicines and Over-The-Counter Medicines), Acne Type (Non-Inflammatory Acne and Inflammatory Acne), and Distribution Channel (Retail Stores, Pharmacies & Drug Stores, and E-Commerce)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

The global acne medication market size was exhibited at USD 13.64 billion in 2022 and is projected to hit around USD 19.82 billion by 2032, growing at a CAGR of 3.81% during the forecast period 2023 to 2032.

Key Pointers:

• North America accounted for the largest share of revenue in 2022, and is anticipated to maintain its dominance from 2023 to 2032
• By therapeutic class, the retinoids segment accounted for the largest share in 2022.
• The salicylic acid segment is expected to grow at the highest CAGR from 2023 to 2032.
• The prescription medicine segment is the revenue generating segment in the acne medication market
• The over-the-counter medicine segment is anticipated to record a CAGR of 3.21% during the forecast period,

Acne Medication Market Report Scope

Acne or acne vulgaris is one of the most common skin conditions majorly caused by changes in skin structures. It affects millions of adolescents across the world. It is characterized by pimples, blackheads, oily skin, and scarring. There are two types of acne including non-inflammatory and inflammatory, where the latter takes longer duration to heal and can cause permanent effects on skin. It generally affects skin with comparatively high number of sweat glands such as upper part of chest, back, and face. Acne medications are drugs that are indicated for treatment of acne. These include several prescription and over-the-counter medicines such as retinoids, isotretinoin, antibiotics, salicylic acid, benzoyl peroxide, and oral contraceptives.

Increase in prevalence of acne diseases is the major factor that contributes toward growth of the acne medication market. Moreover, other factors that fuel the market include unhealthy urban lifestyle and presence of robust acne medications in pipeline. However, side-effects associated with the use of acne medications and presence of alternative treatment impede the market growth. Conversely, development of effective medications with lesser side effects and high market potential in untapped emerging economies are expected to provide lucrative growth opportunities for the market growth.

The COVID-19 outbreak that started from Wuhan city of China has now wide spread globally. Almost every nation is dealing with the outbreak. The acne medication market is impacted by the pandemic as most countries adopted lockdown to combat the pandemic. This pandemic has disrupted growth in many economies across various domains. The COVID-19 pandemic has stressed healthcare systems worldwide and many dermatology clinics are no longer open for public services, owing to safety. Several hospitals and clinics have been transformed into COVID-19 centers using pandemic-designated hospital structures for treatment and isolation of patients with a COVID-19 infection. Furthermore, owing to lockdown, many patients are not able to visit dermatology clinics and pharmacies to pick up prescriptions. In this pandemic situation factors such as telemedicine has become an appropriate and effective way to offer necessary dermatological services to patients with acne.

The global acne medication market is segmented into therapeutic class, formulation, type, acne type, distribution channel, and region. By therapeutic class, the market is divided into retinoids, antibiotics, salicylic acid, benzoyl peroxide, and others. The retinoids segment is further classified into topical retinoid & combination retinoid and oral retinoid (isotretinoin). Moreover, the antibiotics segment is further sub segmented into topical antibiotics & combination antibiotics and oral antibiotics. On the basis of formulation, the market is bifurcated into topical medication and oral medication. By type, it is divided into prescription medicine and over-the-counter (OTC) medicine. By acne type, it is fragmented into non-inflammatory and inflammatory acne. By distribution channel, it is classified into retail Store, pharmacy & drug store, and e-commerce. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the prominent players in the Acne Medication Market include:

• Almirall SA.,
• Bausch Health Companies Inc., 
• GlaxoSmithKline Plc (GSK),
• Johnson & Johnson,
• Galderma S.A,
• Mayne Pharma Group Limited, 
• Mylan N.V., 
• Pfizer Inc., 
• Sun Pharmaceutical Industries Limited, 
• Teva Pharmaceutical Industries Ltd.

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Acne Medication market.

By Therapeutic Class

• Retinoid
  • Topical Retinoid & Combination Retinoid
  • Oral Retinoid (Isotretinoin)
• Antibiotic
  • Topical Antibiotic & Combination Antibiotics
  • Oral Antibiotics
• Salicylic Acid
• Benzoyl Peroxide
• Other medications

By Formulation

• Topical Medication
• Oral Medication

By Type

• Prescription Medicine
• Over-the-counter medicines

By Acne Type

• Non-inflammatory acne
• Inflammatory acne

By Distribution Channel

• Retail Store
• Pharmacy & Drug Store
• E-Commerce

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)